CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: alanine
Accession: CHEBI:16449
browse the term
Definition: An alpha-amino acid that consists of propionic acid bearing an amino substituent at position 2.
Synonyms: related_synonym: 2-Aminopropanoic acid; 2-Aminopropionic acid; A; ALA; Alanin; Formula=C3H7NO2; InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6); InChIKey=QNAYBMKLOCPYGJ-UHFFFAOYSA-N; SMILES=CC(N)C(O)=O; alanina
alt_id: CHEBI:13748; CHEBI:22277; CHEBI:2539
xref: CAS:302-72-7; Drug_Central:4306; Gmelin:2449; KEGG:C01401; PMID:17439666; PMID:22264337; Reaxys:635807; Wikipedia:Alanine
cyclic_relationship: is_conjugate_acid_of CHEBI:32439; is_conjugate_base_of CHEBI:32440; is_tautomer_of CHEBI:66916
G
Gria3
glutamate ionotropic receptor AMPA type subunit 3
affects response to substance
ISO
GRIA3 protein affects the susceptibility to 5-fluorowillardiine
CTD
PMID:15264227
NCBI chr X:120,238,515...120,504,106
Ensembl chr X:120,238,534...120,504,096
G
Cacna1h
calcium voltage-gated channel subunit alpha1 H
multiple interactions
ISO
3-cyanoalanine inhibits the reaction [[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Cyclophosphamide] results in increased expression of CACNA1H protein]
CTD
PMID:29129814
NCBI chr10:14,390,104...14,448,204
Ensembl chr10:14,390,113...14,448,376
G
Egr1
early growth response 1
multiple interactions
ISO
3-cyanoalanine inhibits the reaction [[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Cyclophosphamide] results in increased expression of EGR1 protein]
CTD
PMID:29129814
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Usp5
ubiquitin specific peptidase 5
multiple interactions
ISO
3-cyanoalanine inhibits the reaction [[N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine co-treated with Cyclophosphamide] results in increased expression of USP5 protein]
CTD
PMID:29129814
NCBI chr 4:157,619,663...157,634,681
Ensembl chr 4:157,619,643...157,634,711
G
Ctsd
cathepsin D
multiple interactions
EXP
alliin affects the reaction [Isoproterenol affects the activity of CTSD protein]
CTD
PMID:17623887
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
G
Fasn
fatty acid synthase
multiple interactions
ISO
alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of FASN protein]
CTD
PMID:29305303
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
G
Fgf2
fibroblast growth factor 2
decreases secretion multiple interactions
ISO
alliin results in decreased secretion of FGF2 protein alliin promotes the reaction [FGF2 protein results in increased expression of TP53 protein]
CTD
PMID:16351512
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
multiple interactions
EXP ISO
alliin inhibits the reaction [Isoproterenol results in increased activity of HMGCR protein] alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of HMGCR mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of HMGCR protein]
CTD
PMID:16640830 PMID:29305303
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
G
Lcat
lecithin cholesterol acyltransferase
multiple interactions
EXP
alliin inhibits the reaction [Isoproterenol results in decreased activity of LCAT protein]
CTD
PMID:16640830
NCBI chr19:33,834,748...33,838,214
Ensembl chr19:33,834,403...33,838,231
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF1 mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF1 protein]
CTD
PMID:29305303
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Srebf2
sterol regulatory element binding transcription factor 2
multiple interactions
ISO
alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF2 mRNA]; alliin inhibits the reaction [1,3-dichloro-2-propanol results in increased expression of SREBF2 protein]
CTD
PMID:29305303
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
G
Tp53
tumor protein p53
multiple interactions
ISO
alliin promotes the reaction [FGF2 protein results in increased expression of TP53 protein]
CTD
PMID:16351512
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Vegfa
vascular endothelial growth factor A
decreases secretion
ISO
alliin results in decreased secretion of VEGFA protein
CTD
PMID:16351512
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Ddit3
DNA-damage inducible transcript 3
multiple interactions
ISO
2-(methylamino)isobutyric acid inhibits the reaction [arsenite results in increased expression of DDIT3 mRNA]
CTD
PMID:22215663
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Hspa5
heat shock protein family A (Hsp70) member 5
multiple interactions
ISO
2-(methylamino)isobutyric acid inhibits the reaction [arsenite results in increased expression of HSPA5 mRNA]
CTD
PMID:22215663
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Igf1
insulin-like growth factor 1
increases uptake multiple interactions
EXP
IGF1 protein results in increased uptake of 2-(methylamino)isobutyric acid oxophenylarsine inhibits the reaction [IGF1 protein results in increased uptake of 2-(methylamino)isobutyric acid]
CTD
PMID:1928324
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Ins1
insulin 1
increases uptake increases transport multiple interactions
EXP
INS1 protein results in increased uptake of 2-(methylamino)isobutyric acid INS1 protein results in increased transport of 2-(methylamino)isobutyric acid Wortmannin inhibits the reaction [INS1 protein results in increased uptake of 2-(methylamino)isobutyric acid]
CTD
PMID:1847587 PMID:9877156
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions
ISO
2-(methylamino)isobutyric acid inhibits the reaction [arsenite results in increased phosphorylation of RPS6KB1 protein]
CTD
PMID:22215663
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Slc38a2
solute carrier family 38, member 2
multiple interactions
ISO
SLC38A2 mutant form inhibits the reaction [arsenite results in increased transport of 2-(methylamino)isobutyric acid]
CTD
PMID:22215663
NCBI chr 7:127,851,267...127,863,482
Ensembl chr 7:127,851,267...127,863,436
G
Dek
DEK proto-oncogene
multiple interactions
ISO
DEK protein results in increased chemical synthesis of and results in increased secretion of Alanine
CTD
PMID:28558019
NCBI chr17:17,580,804...17,602,825
Ensembl chr17:17,580,843...17,602,808
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases abundance multiple interactions
ISO
IDH2 protein mutant form results in decreased abundance of Alanine Triazines inhibits the reaction [IDH2 protein mutant form results in decreased abundance of Alanine]
CTD
PMID:27469509
NCBI chr 1:134,038,644...134,057,969
Ensembl chr 1:134,029,772...134,058,025
G
Alad
aminolevulinate dehydratase
decreases activity
EXP
Selenocysteine analog results in decreased activity of ALAD protein
CTD
PMID:14630126
NCBI chr 5:75,961,993...75,972,334
Ensembl chr 5:75,961,993...75,972,474
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
multiple interactions
ISO
Selenocysteine inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of FOS protein]; Selenocysteine inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of FOS protein]
CTD
PMID:14572605
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
G
Gsta2
glutathione S-transferase alpha 2
increases expression
EXP
Selenocysteine results in increased expression of GSTA2 mRNA
CTD
PMID:12034368
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
G
Gsta3
glutathione S-transferase alpha 3
increases expression
EXP
Selenocysteine results in increased expression of GSTA3 mRNA
CTD
PMID:12034368
NCBI chr 9:23,658,574...23,684,240
Ensembl chr 9:23,658,574...23,684,240
G
Gsta5
glutathione S-transferase alpha 5
increases expression
EXP
Selenocysteine results in increased expression of GSTA5 mRNA
CTD
PMID:12034368
NCBI chr 8:79,105,561...79,117,472
Ensembl chr 8:79,105,661...79,117,472
G
Gstp1
glutathione S-transferase pi 1
increases expression
EXP
Selenocysteine results in increased expression of GSTP1 mRNA
CTD
PMID:12034368
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
Selenocysteine inhibits the reaction [Lipopolysaccharides affects the localization of and affects the activity of RELA protein]; Selenocysteine inhibits the reaction [Peroxynitrous Acid affects the localization of and affects the activity of RELA protein]
CTD
PMID:14572605
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Kyat1
kynurenine aminotransferase 1
increases amination
ISO
KYAT1 protein results in increased amination of lanthionine
CTD
PMID:22093698
NCBI chr 3:13,459,598...13,493,308
Ensembl chr 3:13,459,591...13,493,355
G
Abcb1a
ATP binding cassette subfamily B member 1A
multiple interactions
ISO
LCL161 binds to and affects the activity of ABCB1 protein; LCL161 inhibits the reaction [ABCB1 protein results in increased export of Fluorescent Dyes]; LCL161 inhibits the reaction [ABCB1 protein results in increased export of mitotracker green FM]
CTD
PMID:32497533
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Birc2
baculoviral IAP repeat-containing 2
decreases expression decreases expression
ISO
LCL161 results in decreased expression of BIRC2 protein LCL161 decreases expression of BIRC2 protein in hepatocellular carcinoma cells
CTD RGD
PMID:32497533 PMID:24976294
RGD:153305953
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
G
Birc3
baculoviral IAP repeat-containing 3
decreases expression
ISO
LCL161 decreases expression of BIRC3 protein in hepatocellular carcinoma cells
RGD
PMID:24976294
RGD:153305953
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
G
Birc5
baculoviral IAP repeat-containing 5
decreases expression
ISO
LCL161 results in decreased expression of BIRC5 protein
CTD
PMID:32497533
NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
G
Xiap
X-linked inhibitor of apoptosis
decreases expression
ISO
LCL161 decreases expression of XIAP protein in hepatocellular carcinoma cells
RGD
PMID:24976294
RGD:153305953
NCBI chr X:120,890,537...120,938,413
Ensembl chr X:120,897,907...120,934,700
G
Cyp2c6
cytochrome P450, family 2, subfamily C, polypeptide 6
decreases expression
ISO
metalaxyl results in decreased expression of CYP2C19 protein
CTD
PMID:32194361
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
G
Cyp7a1
cytochrome P450 family 7 subfamily A member 1
decreases expression
ISO
metalaxyl results in decreased expression of CYP7A1 protein
CTD
PMID:32194361
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
G
Ncoa2
nuclear receptor coactivator 2
multiple interactions
ISO
N-benzoylalanine promotes the reaction [THRA protein binds to NCOA2 protein]; N-benzoylalanine promotes the reaction [THRB protein binds to NCOA2 protein]
CTD
PMID:31566444
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
G
Thra
thyroid hormone receptor alpha
multiple interactions
ISO
N-benzoylalanine promotes the reaction [THRA protein binds to NCOA2 protein]
CTD
PMID:31566444
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
G
Thrb
thyroid hormone receptor beta
multiple interactions affects binding
ISO
N-benzoylalanine promotes the reaction [THRB protein binds to NCOA2 protein] N-benzoylalanine binds to THRB protein
CTD
PMID:31566444
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
G
Abcc1
ATP binding cassette subfamily C member 1
multiple interactions
ISO
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of ABCC1
CTD
PMID:15897249
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc4
ATP binding cassette subfamily C member 4
multiple interactions decreases expression
EXP
Isoflavones promotes the reaction [selenomethylselenocysteine results in decreased expression of ABCC4 mRNA]
CTD
PMID:19025659
NCBI chr15:95,541,186...95,774,898
Ensembl chr15:95,542,315...95,774,283
G
Apaf1
apoptotic peptidase activating factor 1
increases expression
ISO
selenomethylselenocysteine metabolite results in increased expression of APAF1 mRNA
CTD
PMID:25321483
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
G
Ar
androgen receptor
decreases expression
ISO EXP
selenomethylselenocysteine results in decreased expression of AR protein selenomethylselenocysteine results in decreased expression of AR mRNA
CTD
PMID:16637076 PMID:19025659
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bak1
BCL2-antagonist/killer 1
increases expression
ISO
selenomethylselenocysteine metabolite results in increased expression of BAK1 mRNA
CTD
PMID:25321483
NCBI chr20:5,100,480...5,109,669
Ensembl chr20:5,100,480...5,109,264
G
Banp
Btg3 associated nuclear protein
increases expression
ISO
selenomethylselenocysteine results in increased expression of BANP mRNA
CTD
PMID:18514395
NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738
G
Bcl2
BCL2, apoptosis regulator
decreases expression multiple interactions
ISO EXP
selenomethylselenocysteine results in decreased expression of BCL2 mRNA [selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein selenomethylselenocysteine results in decreased expression of BCL2 protein
CTD
PMID:11396176 PMID:19360359
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
decreases expression
ISO
selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA
CTD
PMID:25321483
NCBI chr 3:141,253,508...141,304,582
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l11
Bcl2-like 11
increases expression
ISO
selenomethylselenocysteine metabolite results in increased expression of BCL2L11 mRNA
CTD
PMID:25321483
NCBI chr 3:115,366,783...115,404,068
Ensembl chr 3:115,366,646...115,404,068
G
Bmal1
basic helix-loop-helix ARNT like 1
decreases expression
EXP
selenomethylselenocysteine results in decreased expression of BMAL1 mRNA
CTD
PMID:19122877
NCBI chr 1:167,331,756...167,430,235
Ensembl chr 1:167,331,633...167,430,231
G
Bmf
Bcl2 modifying factor
multiple interactions increases expression
ISO
4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form]; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]; HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter]; selenomethylselenocysteine metabolite inhibits the reaction [STAT3 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter]; selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter]; STAT3 protein inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA] selenomethylselenocysteine metabolite results in increased expression of BMF protein selenomethylselenocysteine metabolite results in increased expression of BMF mRNA; selenomethylselenocysteine metabolite results in increased expression of BMF protein
CTD
PMID:25321483
NCBI chr 3:105,499,534...105,520,159
Ensembl chr 3:105,499,538...105,520,145
G
Casp3
caspase 3
increases activity multiple interactions increases expression
ISO
selenomethylselenocysteine results in increased activity of CASP3 protein BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP3 protein modified form]
CTD
PMID:15318939 PMID:25321483
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression multiple interactions
ISO
selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP6 protein modified form]
CTD
PMID:25321483
NCBI chr 2:218,466,063...218,478,503
Ensembl chr 2:218,466,076...218,478,502
G
Casp8
caspase 8
increases expression
ISO
selenomethylselenocysteine metabolite results in increased expression of CASP8 protein modified form
CTD
PMID:25321483
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
multiple interactions increases expression
ISO
BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of CASP9 protein modified form]
CTD
PMID:25321483
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Ccna2
cyclin A2
decreases expression
EXP
selenomethylselenocysteine results in decreased expression of CCNA2 protein
CTD
PMID:11396176
NCBI chr 2:119,427,239...119,433,645
Ensembl chr 2:119,426,089...119,433,577
G
Ccnd1
cyclin D1
decreases expression multiple interactions
ISO EXP
selenomethylselenocysteine results in decreased expression of CCND1 protein selenomethylselenocysteine results in decreased expression of CCND1 mRNA; selenomethylselenocysteine results in decreased expression of CCND1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of CCND1 protein
CTD
PMID:11396176 PMID:18855134 PMID:19276161
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
G
Cdk2
cyclin dependent kinase 2
multiple interactions
ISO
selenomethylselenocysteine results in decreased phosphorylation of and results in decreased activity of CDK2 protein
CTD
PMID:10656618
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
selenomethylselenocysteine metabolite results in increased expression of CDKN1A protein [Aminooxyacetic Acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of CDKN1A protein
CTD
PMID:25321483
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
increases expression
EXP
selenomethylselenocysteine results in increased expression of CDKN1B protein
CTD
PMID:11396176 PMID:19276161
NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
G
Ces1d
carboxylesterase 1D
increases expression
ISO
selenomethylselenocysteine results in increased expression of CES1
CTD
PMID:15897249
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
G
Chmp1a
charged multivesicular body protein 1A
increases expression
ISO
selenomethylselenocysteine results in increased expression of CHMP1A mRNA
CTD
PMID:18514395
NCBI chr19:51,238,153...51,246,433
Ensembl chr19:51,238,160...51,246,436
G
Col1a1
collagen type I alpha 1 chain
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of COL1A1 mRNA; selenomethylselenocysteine results in decreased expression of COL1A1 protein
CTD
PMID:18514395
NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of COL1A2 mRNA; selenomethylselenocysteine results in decreased expression of COL1A2 protein
CTD
PMID:18514395
NCBI chr 4:32,563,938...32,598,868
Ensembl chr 4:32,563,381...32,598,867
G
Col4a5
collagen type IV alpha 5 chain
increases expression
ISO
selenomethylselenocysteine results in increased expression of COL4A5 mRNA
CTD
PMID:18514395
NCBI chr X:105,118,762...105,322,699
Ensembl chr X:105,118,820...105,322,692
G
Col6a1
collagen type VI alpha 1 chain
increases expression
ISO
selenomethylselenocysteine results in increased expression of COL6A1 mRNA
CTD
PMID:18514395
NCBI chr20:11,906,105...11,924,599
Ensembl chr20:11,905,957...11,924,597
G
Col7a1
collagen type VII alpha 1 chain
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of COL7A1 mRNA
CTD
PMID:18514395
NCBI chr 8:109,604,877...109,637,249
Ensembl chr 8:109,604,861...109,637,252
G
Cry2
cryptochrome circadian regulator 2
increases expression
EXP
selenomethylselenocysteine results in increased expression of CRY2 mRNA
CTD
PMID:19122877
NCBI chr 3:78,374,995...78,405,001
Ensembl chr 3:78,374,995...78,404,965
G
Cyp3a9
cytochrome P450, family 3, subfamily a, polypeptide 9
multiple interactions
ISO
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of CYP3A5
CTD
PMID:15897249
NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
G
Dbp
D-box binding PAR bZIP transcription factor
increases expression
EXP
selenomethylselenocysteine results in increased expression of DBP mRNA
CTD
PMID:19122877
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
selenomethylselenocysteine results in increased expression of DDIT3 mRNA
CTD
PMID:10656618
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dhcr24
24-dehydrocholesterol reductase
decreases expression
EXP
selenomethylselenocysteine results in decreased expression of DHCR24 mRNA
CTD
PMID:19025659
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
G
Drg1
developmentally regulated GTP binding protein 1
multiple interactions
ISO
[selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of DRG1
CTD
PMID:15897249
NCBI chr14:78,103,876...78,119,976
Ensembl chr14:78,103,876...78,119,953
G
Ep300
E1A binding protein p300
multiple interactions
ISO
selenomethylselenocysteine metabolite promotes the reaction [EP300 protein binds to BMF promoter]
CTD
PMID:25321483
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
G
Esr1
estrogen receptor 1
decreases expression multiple interactions
ISO
selenomethylselenocysteine results in decreased expression of ESR1 protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of ESR1 protein
CTD
PMID:18855134
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
G
Faslg
Fas ligand
multiple interactions
ISO
[selenomethylselenocysteine co-treated with irinotecan] results in increased expression of FASLG
CTD
PMID:15897249
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
selenomethylselenocysteine results in increased expression of GADD45A mRNA
CTD
PMID:10656618
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gpx1
glutathione peroxidase 1
increases activity increases expression
ISO
selenomethylselenocysteine results in increased activity of GPX1 protein selenomethylselenocysteine results in increased expression of GPX1 mRNA; selenomethylselenocysteine results in increased expression of GPX1 protein
CTD
PMID:18514395 PMID:19033020
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Gpx4
glutathione peroxidase 4
increases expression
ISO
selenomethylselenocysteine results in increased expression of GPX4 mRNA
CTD
PMID:18514395
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
G
Grik1
glutamate ionotropic receptor kainate type subunit 1
increases expression
ISO
selenomethylselenocysteine results in increased expression of GRIK1 mRNA
CTD
PMID:18514395
NCBI chr11:27,169,739...27,571,131
Ensembl chr11:27,169,740...27,570,645
G
Grik3
glutamate ionotropic receptor kainate type subunit 3
increases expression
ISO
selenomethylselenocysteine results in increased expression of GRIK3 mRNA
CTD
PMID:18514395
NCBI chr 5:137,767,865...137,989,617
Ensembl chr 5:137,767,865...137,984,307
G
Hdac8
histone deacetylase 8
multiple interactions
ISO
HDAC8 inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]; selenomethylselenocysteine metabolite inhibits the reaction [HDAC8 protein binds to BMF promoter]
CTD
PMID:25321483
NCBI chr X:67,385,288...67,593,014
Ensembl chr X:67,385,289...67,592,923
G
Igf1r
insulin-like growth factor 1 receptor
increases expression
ISO
selenomethylselenocysteine results in increased expression of IGF1R mRNA
CTD
PMID:18514395
NCBI chr 1:121,549,831...121,838,548
Ensembl chr 1:121,550,743...121,831,777
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
increases phosphorylation
EXP
selenomethylselenocysteine results in increased phosphorylation of JUN protein
CTD
PMID:19276161
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
G
Klk1
kallikrein 1
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of KLK3 protein
CTD
PMID:16637076
NCBI chr 1:94,642,644...94,646,760
Ensembl chr 1:94,642,687...94,646,754
G
Mki67
marker of proliferation Ki-67
multiple interactions decreases expression
ISO
[selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of MKI67 protein selenomethylselenocysteine results in decreased expression of MKI67 protein
CTD
PMID:18855134
NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
G
Msrb1
methionine sulfoxide reductase B1
increases expression
ISO
selenomethylselenocysteine results in increased expression of MSRB1 mRNA
CTD
PMID:18514395
NCBI chr10:13,764,883...13,770,609
Ensembl chr10:13,764,883...13,770,609
G
Nfkb1
nuclear factor kappa B subunit 1
multiple interactions
ISO
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein]
CTD
PMID:21213327
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]
CTD
PMID:21213327
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
increases expression
ISO
selenomethylselenocysteine results in increased expression of P4HA1 mRNA
CTD
PMID:18514395
NCBI chr20:27,302,046...27,352,098
Ensembl chr20:27,302,141...27,352,786
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases expression
ISO
[Aminooxyacetic Acid results in decreased metabolism of selenomethylselenocysteine] which results in decreased expression of PARP1 protein modified form; BMF protein promotes the reaction [selenomethylselenocysteine metabolite results in increased expression of PARP1 protein modified form]
CTD
PMID:25321483
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Per2
period circadian regulator 2
increases expression
EXP
selenomethylselenocysteine results in increased expression of PER2 mRNA
CTD
PMID:19122877
NCBI chr 9:92,007,289...92,049,551
Ensembl chr 9:92,007,296...92,049,459
G
Per3
period circadian regulator 3
increases expression
EXP
selenomethylselenocysteine results in increased expression of PER3 mRNA
CTD
PMID:19122877
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
G
Pgr
progesterone receptor
decreases expression multiple interactions
ISO
selenomethylselenocysteine results in decreased expression of PGR protein [selenomethylselenocysteine co-treated with Tamoxifen] results in decreased expression of PGR protein
CTD
PMID:18855134
NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
selenomethylselenocysteine results in increased expression of PPP1R15A mRNA
CTD
PMID:10656618
NCBI chr 1:96,000,053...96,003,128
Ensembl chr 1:96,000,058...96,003,171
G
Prkce
protein kinase C, epsilon
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of PRKCE protein
CTD
PMID:10656618
NCBI chr 6:7,965,048...8,451,966
Ensembl chr 6:7,965,048...8,451,719
G
Prkcz
protein kinase C, zeta
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of PRKCZ protein
CTD
PMID:10656618
NCBI chr 5:165,817,786...165,930,386
Ensembl chr 5:165,819,466...165,930,367
G
Rab3b
RAB3B, member RAS oncogene family
increases expression
ISO
selenomethylselenocysteine results in increased expression of RAB3B mRNA
CTD
PMID:18514395
NCBI chr 5:123,629,562...123,697,410
Ensembl chr 5:123,644,423...123,697,401
G
Rab4a
RAB4A, member RAS oncogene family
increases expression
ISO
selenomethylselenocysteine results in increased expression of RAB4A mRNA
CTD
PMID:18514395
NCBI chr19:51,795,613...51,822,706
Ensembl chr19:51,795,613...51,822,703
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
selenomethylselenocysteine inhibits the reaction [Lipopolysaccharides results in increased localization of RELA protein]
CTD
PMID:21213327
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Scarb1
scavenger receptor class B, member 1
increases expression
ISO
selenomethylselenocysteine results in increased expression of SCARB1 mRNA
CTD
PMID:18514395
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
G
Selenof
selenoprotein F
increases expression
ISO
selenomethylselenocysteine results in increased expression of SELENOF mRNA
CTD
PMID:18514395
NCBI chr 2:233,642,075...233,674,853
Ensembl chr 2:233,641,932...233,674,846
G
Selenop
selenoprotein P
increases expression
ISO
selenomethylselenocysteine results in increased expression of SELENOP mRNA
CTD
PMID:18514395
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
G
Selenow
selenoprotein W
increases expression
ISO
selenomethylselenocysteine results in increased expression of SELENOW mRNA
CTD
PMID:18514395
NCBI chr 1:76,599,441...76,604,514
Ensembl chr 1:76,598,779...76,604,724 Ensembl chr 1:76,598,779...76,604,724
G
Slc3a1
solute carrier family 3 member 1
increases uptake
ISO
SLC3A1 protein results in increased uptake of selenomethylselenocysteine
CTD
PMID:18845132
NCBI chr 6:9,608,169...9,641,881
Ensembl chr 6:9,608,178...9,641,907
G
Slc6a19
solute carrier family 6 member 19
increases uptake
ISO
SLC6A19 protein results in increased uptake of selenomethylselenocysteine
CTD
PMID:18845132
NCBI chr 1:29,586,191...29,604,964
Ensembl chr 1:29,586,195...29,604,962
G
Slc6a20a
solute carrier family 6 member 20a
increases uptake
ISO
SLC6A20B protein results in increased uptake of selenomethylselenocysteine
CTD
PMID:18845132
NCBI chr 8:123,282,325...123,322,609
Ensembl chr 8:123,281,472...123,322,573
G
Snap23
synaptosome associated protein 23
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of SNAP23 mRNA
CTD
PMID:18514395
NCBI chr 3:107,514,088...107,546,177
Ensembl chr 3:107,514,131...107,544,320
G
Sort1
sortilin 1
increases expression
ISO
selenomethylselenocysteine results in increased expression of SORT1 mRNA
CTD
PMID:18514395
NCBI chr 2:195,924,033...196,002,354
Ensembl chr 2:195,924,099...196,002,354
G
Sp3
Sp3 transcription factor
multiple interactions
ISO
selenomethylselenocysteine metabolite promotes the reaction [SP3 protein binds to BMF promoter]
CTD
PMID:25321483
NCBI chr 3:57,811,855...57,857,150
Ensembl chr 3:57,812,075...57,860,342
G
Spp1
secreted phosphoprotein 1
decreases expression
ISO
selenomethylselenocysteine results in decreased expression of SPP1 protein
CTD
PMID:15318939
NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
G
Srd5a1
steroid 5 alpha-reductase 1
multiple interactions
EXP
[selenomethylselenocysteine co-treated with Isoflavones] results in decreased activity of SRD5A1 protein
CTD
PMID:19025659
NCBI chr 1:33,686,069...33,720,468
Ensembl chr 1:33,686,391...33,720,461
G
Stat3
signal transducer and activator of transcription 3
multiple interactions
ISO
selenomethylselenocysteine metabolite inhibits the reaction [STAT3 protein binds to BMF promoter]; STAT3 protein inhibits the reaction [selenomethylselenocysteine metabolite results in increased expression of BMF mRNA]
CTD
PMID:25321483
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
G
Stx3
syntaxin 3
increases expression
ISO
selenomethylselenocysteine results in increased expression of STX3 mRNA
CTD
PMID:18514395
NCBI chr 1:208,617,018...208,686,240
Ensembl chr 1:208,639,115...208,685,805
G
Tnfsf10
TNF superfamily member 10
multiple interactions
ISO
[selenomethylselenocysteine results in decreased expression of BCL2 mRNA] which results in increased activity of TNFSF10 protein
CTD
PMID:19360359
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
G
Trnau1ap
tRNA selenocysteine 1 associated protein 1
increases expression
ISO
selenomethylselenocysteine results in increased expression of TRNAU1AP mRNA
CTD
PMID:18514395
NCBI chr 5:144,507,044...144,524,142
Ensembl chr 5:144,507,615...144,524,131
G
Xpa
XPA, DNA damage recognition and repair factor
multiple interactions
ISO
selenomethylselenocysteine inhibits the reaction [Zinc binds to XPA protein]
CTD
PMID:15265038
NCBI chr 5:60,431,673...60,475,726
Ensembl chr 5:60,431,673...60,475,726
G
Klrc1
killer cell lectin like receptor C1
decreases expression
ISO
sofosbuvir co-treated with ledipasvir decreased expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 4:163,142,142...163,152,425
Ensembl chr 4:163,147,189...163,152,425
G
Ncr1
natural cytotoxicity triggering receptor 1
affects expression
ISO
sofosbuvir co-treated with ledipasvir affects expression of NCR1 protein in natural killer cells
RGD
PMID:31218578
RGD:40400920
NCBI chr 1:69,614,744...69,622,594
Ensembl chr 1:69,616,601...69,660,558
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19880
role
19850
biological role
19848
biochemical role
19556
metabolite
19544
fundamental metabolite
14528
alanine
115
D-alanine +
2
L-alanine +
106
L-alanine-2,3,3,3-d4
0
alanine derivative +
113
alanine residue +
0
alanine-2,3,3,3-d4
0
alanine-d7
0
alanino group +
0
alanyl group +
0
alanylalanine
0
Path 2
CHEBI ontology
19880
subatomic particle
19878
composite particle
19878
hadron
19878
baryon
19878
nucleon
19878
atomic nucleus
19878
atom
19878
main group element atom
19817
p-block element atom
19817
carbon group element atom
19757
carbon atom
19754
organic molecular entity
19754
heteroorganic entity
19512
organochalcogen compound
19275
organooxygen compound
19191
carbon oxoacid
18658
carboxylic acid
18655
monocarboxylic acid
18004
fatty acid
16838
saturated fatty acid
16560
propionic acid
3874
alanine
115
D-alanine +
2
L-alanine +
106
L-alanine-2,3,3,3-d4
0
alanine derivative +
113
alanine residue +
0
alanine-2,3,3,3-d4
0
alanine-d7
0
alanino group +
0
alanyl group +
0
alanylalanine
0